Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β
Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams
Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams
View: Text | PDF
Research Article Endocrinology Immunology

Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β

  • Text
  • PDF
Abstract

Glucocorticoid synthesis by adrenal glands (AGs) is regulated by the hypothalamic-pituitary-adrenal axis to facilitate stress responses when the host is exposed to stimuli. Recent studies implicate macrophages as potential steroidogenic regulators, but the molecular mechanisms by which AG macrophages exert such influence remain unclear. In this study, we investigated the role of AG macrophages in response to cold challenge or atherosclerotic inflammation as physiologic models of acute or chronic stress. Using single-cell RNA sequencing, we observed dynamic AG macrophage polarization toward classical activation and lipid-associated phenotypes following acute or chronic stimulation. Among transcriptional alterations induced in macrophages, triggering receptor expressed on myeloid cells 2 (Trem2) was highlighted because of its upregulation following stress. Conditional deletion of macrophage Trem2 revealed a protective role in stress responses. Mechanistically, Trem2 deletion led to increased AG macrophage death, abolished the TGF-β–producing capacity of AG macrophages, and resulted in enhanced glucocorticoid production. In addition, enhanced glucocorticoid production was replicated by blockade of TGF-β signaling. Together, these observations suggest that AG macrophages restrict steroidogenesis through Trem2 and TGF-β, which opens potential avenues for immunotherapeutic interventions to resolve stress-related disorders.

Authors

Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams

×

Figure 7

TGF-β inhibition promotes steroidogenesis.

Options: View larger image (or click on image) Download as PowerPoint
TGF-β inhibition promotes steroidogenesis.
(A) Trem2 and Tgfb1 expressio...
(A) Trem2 and Tgfb1 expression level shown in UMAP. (B) Quantification of Tgfb1+ immune cells. Tgfb1 positivity determined by normalized Tgfb1 expression > 0. (C) Schematic of TGF-β neutralization in in vitro Y1-WT BV2 coculture. WT BV2 and Y1 were cultured for 3 hours. αTGF-β neutralizing antibody–conditioned (0.3%) medium was reconstituted with ACTH. Cells were further cultured for 3 hours and harvested for flow cytometry. (D) Normalized (to vehicle control) percentage of StAR+ Y1 cells cultured with or without αTGF-β antibody. n = 5–6 replicates. Significance determined by ANOVA, ***P < 0.001, ****P < 0.0001. (E) Schematic of TGF-βR antagonism by LY573636 in B6 mice. Mice received 150 μL (20 mg/mL in DMSO) LY573636 1 day before cold challenge and daily during cold housing. (F) Immunofluorescence staining showing StAR expression in AG cortex. (G) Mean intensity of StAR (green pixels) in vehicle or LY573636-treated animals. Green: DMSO vehicle control, n = 3. Red: LY573636 treated, n = 3. Significance determined by Student’s t test, **P < 0.005. (H) ELISA analysis of corticosterone concentration in AG tissue. Green: DMSO vehicle control, n = 5. Red: LY573636 treated, n = 4. Data were normalized to vehicle control. Significance determined by Student’s t test, **P < 0.005.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts